Product image of Norditropin Nordiflex (Somatropin) supplied by GNH India

Norditropin Nordiflex

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Nordiflex (Somatropin)

Somatropin, the active ingredient in Norditropin Nordiflex, is a growth hormone presented as a solution for injection (pen injector) for subcutaneous use. It is indicated for treating growth hormone deficiency in children and adults, as well as growth disorders associated with genetic syndromes such as Turner and Prader‑Willi, and promotes normal growth of bone and muscle tissue.

GNH India supplies Norditropin Nordiflex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Nordiflex, a recombinant human growth hormone, is used to manage conditions related to growth hormone deficiency and associated growth disorders.

  • Growth hormone deficiency in children: stimulates linear growth and increases height velocity.
  • Growth hormone deficiency in adults: improves body composition, bone density, and metabolic profile.
  • Turner syndrome: enhances stature gain during puberty.
  • Prader‑Willi syndrome: supports growth and improves body composition.
  • Chronic renal insufficiency-associated growth failure: promotes growth in pediatric patients with renal disease.
  • Idiopathic short stature: facilitates increased growth rate when other causes are excluded.

How It Works

  • Somatropin is a recombinant form of human growth hormone that binds to growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling pathway. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and other downstream mediators, leading to increased protein synthesis, cartilage proliferation, and bone growth, while also influencing metabolism of carbohydrates and lipids.

Side Effects

Somatropin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Injection site pain: mild discomfort or erythema at the injection site.
  • Headache: transient headache reported by some patients.
  • Joint stiffness: occasional arthralgia or reduced joint mobility.
  • Edema: peripheral swelling, especially in the lower extremities.

Serious or Rare Side Effects

  • Intracranial hypertension: signs include headache, visual changes, and nausea.
  • Slipped epiphysis: premature closure of growth plates leading to bone deformities.
  • Severe allergic reaction: rash, urticaria, or anaphylaxis requiring immediate medical attention.
  • Hyperglycemia: elevated blood glucose levels, particularly in patients with diabetes risk.

Precautions & Warnings

When prescribing or handling Norditropin Nordiflex, several precautions should be observed to ensure safety and efficacy.

  • Dose titration: adjust the dose based on IGF‑1 levels, growth response, and patient tolerance.
  • Monitoring: regularly assess glucose metabolism, thyroid function, and growth parameters.
  • Contraindications: avoid use in patients with active malignancy or known hypersensitivity to somatropin.
  • Pregnancy and lactation: safety has not been established; use only if the potential benefit justifies the risk.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the pen injector.

Avoid Interactions

Somatropin can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • Glucocorticoids: may antagonize growth hormone effects and reduce IGF‑1 response.
  • Oral estrogen therapy: can diminish the anabolic action of growth hormone.
  • Insulin: concurrent use may increase risk of hypoglycemia.

Moderate Interactions (Monitor Closely)

  • Diabetes mellitus: somatropin may exacerbate hyperglycemia; monitor blood glucose.
  • Thyroid hormone replacement: may require dose adjustments due to altered metabolism.

Frequently Asked Questions

Norditropin Nordiflex is a recombinant human growth hormone indicated for treating growth hormone deficiency in children and adults, as well as for growth disorders associated with Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency‑related growth failure, and idiopathic short stature.

Somatropin binds to growth hormone receptors on target cells, activating intracellular JAK2‑STAT5 signaling. This triggers the liver to produce insulin‑like growth factor‑1 (IGF‑1) and other growth‑promoting proteins, which together stimulate bone growth, muscle development, and metabolic processes.

The dose of Norditropin Nordiflex is individualized. A qualified prescriber determines the appropriate amount based on the patient’s age, weight, IGF‑1 levels, and clinical response, and then provides specific administration instructions.

Safety of somatropin in pregnancy and lactation has not been established. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Norditropin Nordiflex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.

Norditropin Nordiflex is a recombinant somatropin formulated for delivery via a pen injector, offering precise dosing and ease of subcutaneous administration. Compared with other GH products, it provides comparable efficacy and safety, with the added convenience of a ready‑to‑use pen device that reduces preparation steps.

Store Norditropin Nordiflex at 2‑8 °C in the original packaging, protected from light. Do not freeze or shake the pen injector. If the product reaches room temperature for a short period, it may be used, but it should be returned to refrigeration promptly.

Norditropin Nordiflex is administered by subcutaneous injection using the pre‑filled pen injector. The prescriber selects the appropriate dose, the patient or caregiver injects into the thigh, abdomen, or upper arm, and rotates injection sites to minimize local reactions.

Serious risks include intracranial hypertension, slipped epiphysis (premature closure of growth plates), severe allergic reactions such as anaphylaxis, and significant hyperglycemia, especially in patients with pre‑existing diabetes or metabolic disorders.

Norditropin Nordiflex should not be used in individuals with active malignancy, known hypersensitivity to somatropin or any excipients, or in patients for whom growth hormone therapy is contraindicated, such as those with uncontrolled diabetes without proper monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT